Features | Partner Sites | Information | LinkXpress
Sign In
SCHILLER AG
AMPRONIX
TERARECON, INC.

Calibration Tools Used to Enhance Ultralow Field MRI Technology

By Medimaging International staff writers
Posted on 16 Dec 2013
Image: NIST physicist Michael Boss positions a prototype NIST phantom in an ultralow-field magnetic resonance imaging scanner at the University of California at Berkeley. NIST phantoms are intended to help assess and validate this experimental imaging method, which offers advantages in diagnosing and monitoring of certain medical conditions (Photo courtesy of NIST).
Image: NIST physicist Michael Boss positions a prototype NIST phantom in an ultralow-field magnetic resonance imaging scanner at the University of California at Berkeley. NIST phantoms are intended to help assess and validate this experimental imaging method, which offers advantages in diagnosing and monitoring of certain medical conditions (Photo courtesy of NIST).
A US technology office has developed prototype calibration tools for an experimental medical imaging technique that offers new benefits in diagnosing and tracking of specific cancers and other medical disorders.

The US National Institute of Standards and Technology (NIST; Gaithersburg, MD, USA) designed, built, and evaluated two prototype phantoms for calibrating ultralow-field (ULF) magnetic resonance imaging (MRI) systems.

The NIST prototypes are the first standard calibration tools for ULF-MRI, offering a quantitative means to assess performance, validate the technique, and directly compare different experimental and clinical MRI scanners. “Tissues that may look the same in clinical MRI can look very different in ULF-MRI, which provides new contrast mechanisms,” NIST physicist Dr. Michael Boss stated. “Our hope is that we can move this technique along to attract more interest from [industry] vendors.”

MRI noninvasively images soft tissues based on measurements of how hydrogen nuclei respond to magnetic fields. ULF-MRI enhances tissue contrast in specific types of MRI scans. Prostate tumors, for example, can be difficult to see with conventional MRI but show up clearly under ULF-MRI. ULF-MRI has also been used in research approaches to image the brain, and assessed in at least one nonmedical application, inspection of liquids at airports.

ULF-MRI also offers practical advantages: the systems are more streamlined, lighter in weight, and less costly than conventional MRI scanners. That is because ULF-MRI operates at much lower magnetic field strengths, measured in micro-Teslas, thousands of times lower than conventional MRI, which operates at up to 3 Teslas and requires large magnets. The low magnetic field strength means ULF-MRI requires the most sensitive magnetometers available: superconducting quantum interference devices (SQUIDs). This is convenient in that it makes ULF-MRI suitable for combining with other SQUID-based imaging techniques such as magnetoencephalography.

NIST scientists earlier designed phantoms for standard MRI systems and also have extensive experience both making and using SQUIDs. NIST’s new ULF-MRI phantoms are short plastic cylinders, shaped like hockey pucks but a bit smaller, containing six or 10 plastic jars filled with various salt solutions that become magnetized in a magnetic field. Each phantom measures a different aspect of scanner performance such as spatial resolution. NIST researchers tested the new phantoms on both a conventional MRI system at the University of Colorado Health Sciences Center (Denver, CO, USA) and a research ULF-MRI scanner at the University of California (UC) at Berkeley, where the technique was first demonstrated about than 10 years ago.

Tests findings revealed that the prototype phantoms are well matched to ULF-MRI applications and they allow direct comparison of ULF and clinical MRI system performance. NIST researchers now plan to integrate design improvements based on lessons gleaned from the prototypes, with the aim of improving phantom stability and providing traceability to standard measurement units. NIST and the University of California (UC) Berkeley (USA) researchers also plan to work together to develop ULF-MRI technology for the detection of prostate and breast cancers.

NIST’s phantoms for conventional MRI systems are currently being tested by hospitals and MRI manufacturers, and Sigma-K Corp. (Durham, NC, USA) is devising ways for making copies for more widespread distribution under a NIST Small Business Innovation Research Award (SBIR).

The study’s findings were published online November 26, 2013, in the journal Magnetic Resonance in Medicine.

Related Links:

National Institute of Standards and Technology
University of California, Berkeley
Sigma-K



RADCAL
RTI ELECTRONICS AB
SuperSonic Imagine

Channels

Radiography

view channel

Leading Cancer Center Among First in Europe to Treat Patients Using Robotic Patient-Positioning Radiotherapy Couch

A Viennese hospital has become one of the first oncology departments in Europe to introduce clinical treatments using a robotic radiotherapy patient-positioning couch. Kaiser-Franz-Josef Hospital (KFJ; Vienna, Austria) has introduced this enhanced patient positioning device, which enables more flexibility during radiotherapy... Read more

Ultrasound

view channel
Image: Very high magnification micrograph of fibrolamellar hepatocellular carcinoma showing the characteristic laminated fibrosis between the tumor cells with a low N/C ratio. H&E stain (Photo courtesy of Wikimedia Commons).

Hepatocellular Carcinoma Screening Linked with Curative Treatment and Longer Survival in Cirrhosis Patients

Investigators discovered that patients with cirrhosis who underwent surveillance (using liver ultrasound with or without measurement of serum alpha fetoprotein) for hepatocellular carcinoma (HCC) had cancers... Read more

Nuclear medicine

view channel
Image: Micrograph of Hodgkin lymphoma. Lymph node fine-needle aspiration (FNA) specimen. Field stain (Photo courtesy of Wikimedia Commons).

Early PET-Negative Stage I/II Hodgkin Lymphoma Patients Show Increased Risk of Early Relapse when Radiotherapy Is Not Used

Analysis of a new study indicates an increased risk of early relapse when excluding radiotherapy in early positron emission tomography (PET) scan-negative patients with stage I/II Hodgkin’s lymphoma.... Read more

General/Advanced Imaging

view channel

Secondary Light Emission Generated by Plasmonic Nanostructures May Improve Medical Imaging Technology

New clues into light emission at different wavelengths generated by elements known plasmonic nanostructures may help to improve medical imaging technology. A plasmon is a quantum of plasma oscillation. The plasmon is a quasiparticle resulting from the quantization of plasma oscillations just as photons, and phonons are... Read more

Imaging IT

view channel

Enterprise Image-Viewing System Receives FDA Clearance for Mobile Diagnosis on All Modalities

An enterprise image-viewing system is now cleared in the United States for diagnosis on mobile devices, for all imaging modalities (except mammography). Calgary Scientific, Inc. (Calgary, AB, USA) recently reported their latest Class II clearance from the US Food and Drug Administration (FDA). Calgary Scientific worked... Read more

Industry News

view channel

Collaboration Expands Capacity for Proton Therapy Clinical Research and Patient Treatments

Varian Medical Systems (Palo Alto, CA, USA) and the Paul Scherrer Institute (PSI; Villigen PSI, Switzerland) are extending an existing collaboration in the field of proton therapy to offer patients more accurate cancer treatments using intensity-modulated proton therapy (IMPT). Under the agreement, Varian will also... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.